United States Pain Management Therapeutics Market Opportunity

Pain management is one of the fastest growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The pain management therapeutics market in United States has huge potential for growth as high population is affected by medically significant pain. The pain management market is fuelled by the segment like arthritis pain, cancer pain, fibromyalgia, back pain, neuropathic pain, migraine pain, and post-operative pain relief markets.

Pain is a widespread problem across the United States. The pain management market is growing fuelled by cancer pain, back pain, and post-operative pain relief markets. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In most of the cases, such as cancer pain, 50% of the people taking medicines are not satisfied with the results. This is mainly due to the absence of a perfect pain management solution. Pain management can be highly effective only when the underlying disease conditions are cured.

  
The pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The new product approvals and increase in incidence and mortality of chronic conditions will continue to play a significant role in the growth and further development of this market. The higher demand for more efficient drugs for pain treatment is driving the pain-management therapeutics market. Other factors affecting the future of the pain-management segment include an increasing number of surgical procedures being performed, changing lifestyles, and increasing incidences of cancer. The United States market for pain-management therapeutics is predicted to generate over US$ 55 Billion by 2018.

The arthritis pain management therapeutic market is the leading segment of United States pain management market. Back pain is the second largest segment of the United States pain management market. Cancer pain therapeutics market is giving tough competition to back pain. The United States has an increasing incidence of cancer and cancer pain. This provides generous opportunity for market growth and product innovation. The cancer pain management market is likely to be the fastest growing segment within the pain management therapeutics market. The United States market for migraine pain is driven by products with a specific indication for migraine pain such as Imitrex and Zomig. According to Renub Research the pediatric pain management market represents the smallest segment for the pain management.

Comments

Post a Comment

Popular posts from this blog

Global Electric Scooter Market will be US$ 30 Billion by 2025

Image
Renub Research report titled “Global Electric Scooter Market by Country, Product (Retro, Standing/Self Balancing, Folding), Battery Type, Company” Demand for electric scooters on the global market has been growing due to the rising need to regulate international levels of air pollution. Electric scooters are produced using superior technology wherein a rechargeable battery powers the vehicle's electric motor. Because of their fuel economy, smooth running, and eco-friendly appeal, these scooters have gained popularity across several regions. Developing more robust and more efficient electric scooters are expected to push a large customer base into purchasing such vehicles. Besides, international environmental organizations' efforts to encourage electric vehicles are also expected to fuel demand for electric scooters within the global market. Electric scooters have been a commendable achievement for the electric automotive market, and the former is expected to see greater accepta
Read more

Central Nervous System (CNS) Drugs Market Overview

Image
Central Nervous System (CNS) drugs market consists of drugs used for the treatment of diseases have an effect on the brain such as epilepsy, Parkinson’s disease, depression and anxiety. Epilepsy is a chronic brain disorder characterized by frequent abductions. Parkinson’s disease is a degenerative CNS disorder associated with symptoms of rigidity and tremor. According to Parkinson’s disease Foundation nearly 7-10 Million people are affected with Parkinson’s disease across the globe. These diseases affect by the neurodegeneration, autoimmune disorders and trauma. Increase in CNS diseases prevalence rates due to aging population, introduction of new class of drugs and increased expenditure on healthcare are the driving force for the growth of CNS Drugs market . In recent years, there is no drug available to cure Alzheimer’s disease, the available medicines only treat the austerity of symptoms and develop the quality of life to some extent. There are lots of companies such as
Read more

2 Million Electric Cars were sold by 2015

Image
Global Electric car numbers has increased in a phenomenal rate. By the end of 2015 the number of global electric car was slightly less than 2 Million.Hybrid Electric Vehicle controls the highest market share, but it is losing its market share year on year. Plug in Hybrid vehicle and Battery Electric Vehicles will gain most of the volume shares. Electric car is the future of automobile industry. Several car companies are trying to get a foothold into this market. But the credit goes to Toyota for being the first company to bring Hybrid vehicle for commercial sales to the market. Toyota had launched Toyota Prius in 1997, later on company provided the option of “Hybrid Synergy Drive” and Lexus versions as “Lexus Hybrid Drive” on the smaller cars like Camry. Lexus division also produced some hybrid luxury cars.Another automobile company Renault has launched four battery electric vehicles (BEVs), Renault Fluence Z.E., Renault Zoe, Renault Kangoo Z.E. utility van and the Ren
Read more